Trevi Therapeutics, Inc. - Common Stock (NQ:TRVI)

14.49 +0.17 (+1.19%)

Delayed Quote Updated: 11:45 AM EDT, Oct 1, 2026 Add to My Watchlist

Price and Volume

Volume	943,590
Open	14.30
Bid (Size)	14.48 (600)
Ask (Size)	14.50 (700)
Prev. Close	14.32
Today's Range	14.08 - 14.52
52wk Range	8.630 - 20.22
Shares Outstanding	60,069,512
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Trevi Therapeutics Q2 Earnings Call Highlights ↗

August 07, 2026

Trevi Therapeutics (NASDAQ:TRVI) said it began two clinical trials during the second quarter and plans to launch a third study in the third quarter as it advances nalbuphine ER, also known as Haduvio,...

Via MarketBeat

Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters. ↗

June 03, 2026

This clinical-stage biotech targets chronic pruritus and cough with its lead therapy for neurologically mediated diseases.

Via The Motley Fool

Performance

YTD	+21.9%	+21.9%
1 Month	-12.7%	-12.7%
3 Month	-17.7%	-17.7%
6 Month	+25.1%	+25.1%
1 Year	+58.4%	+58.4%

More News

Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030 ↗

May 09, 2026

Via MarketBeat

Trevi Therapeutics Inc. (NASDAQ:TRVI) Beats Q4 2025 EPS Estimates, Gains FDA Alignment for Phase 3 Program ↗

March 17, 2026

Via Chartmill

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings Preview For Trevi Therapeutics ↗

May 07, 2025

Via Benzinga

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗

March 23, 2026

Via The Motley Fool

Trevi Therapeutics (TRVI) Earnings Transcript ↗

March 18, 2026

Via The Motley Fool

TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns ↗

March 09, 2026

Via Stocktwits

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

December 03, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 28, 2025

Via The Motley Fool

Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗

November 27, 2025

Via The Motley Fool

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗

November 27, 2025

Via The Motley Fool

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗

November 27, 2025

Via The Motley Fool

Trevi Therapeutics Inc (NASDAQ:TRVI) Reports Q3 2025 Results, Narrows Loss and Outlines Phase 3 Plans ↗

November 13, 2025

Via Chartmill

A Peek at Trevi Therapeutics's Future Earnings ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 03, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 09, 2025

Via Benzinga

This Adient Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 21, 2025

Via Benzinga

Dow Gains Over 100 Points; US Job Openings Increase In April ↗

June 03, 2025

Via Benzinga

Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients ↗

June 02, 2025

Via Benzinga

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

March 26, 2025

From Avalo Therapeutics

Via GlobeNewswire

Frequently Asked Questions

Is Trevi Therapeutics, Inc. - Common Stock publicly traded?

Yes, Trevi Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Trevi Therapeutics, Inc. - Common Stock trade on?

Trevi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Trevi Therapeutics, Inc. - Common Stock?

The ticker symbol for Trevi Therapeutics, Inc. - Common Stock is TRVI on the Nasdaq Stock Market

What is the current price of Trevi Therapeutics, Inc. - Common Stock?

The current price of Trevi Therapeutics, Inc. - Common Stock is 14.49

When was Trevi Therapeutics, Inc. - Common Stock last traded?

The last trade of Trevi Therapeutics, Inc. - Common Stock was at 10/01/26 11:45 AM ET

What is the market capitalization of Trevi Therapeutics, Inc. - Common Stock?

The market capitalization of Trevi Therapeutics, Inc. - Common Stock is 870.41M

How many shares of Trevi Therapeutics, Inc. - Common Stock are outstanding?

Trevi Therapeutics, Inc. - Common Stock has 870M shares outstanding.